ftInvstr
PFIZER · Healthcare ₹3929.7 +0.66% Mkt Cap ₹17984 Cr

PFIZER

Healthcare Drug Manufacturers - General
₹3929.7
+0.66% today · 30d +3.41%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for PFIZER. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹727 Cr
+13.16% YoY
NET PROFIT
₹313 Cr
+65.72% YoY
OPM
39.85%
+0.13pp YoY
EPS
₹68.47
PE 23.38
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-3.3%, h2=-1.3%, h3=-0.6% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
PFIZER23.38—
GLAXO40.0557.97
RUBICON90.2127.36
CORONA78.1333.8
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
57
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation REASONABLE 60
Growth STEADY 51
Profitability HIGH 90
Technicals WEAK 40
Risk LOW 80
Key Stats
TTM PE
23.38
P/B
4.06
52W HIGH
₹5446.0
OFF HIGH
-27.84%
DIV YIELD
1.91%
MKT CAP
₹17984 Cr
◉ Active Signals
MACDNeutral42.747
RSI(14)Neutral55.34
Near 52W LowBearish9.49
Street Consensus
5 analysts
₹5321.6
mean target
Low ₹4250.0Now ₹3929.7High ₹7319.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PFIZER and at what entry.

Sign up freeSign in